Read further: Diagnostic Yield of Cardiomyopathy and Arrhythmia Genetic Testing
Author - Hippocrates Briefs Team
Empagliflozin for HF-pEF and Its Effects on Patients...
Empagliflozin has been established as one of the possible key treatments for patients with heart...
ACC’s Physician Fee Schedule Proposed Rule Calculator Now...
Just close to a month after the CMS released their 2023 Medicare Physician Fee Schedule proposed...
Trial Study to Show Empagliflozin Outcomes In Patients of...
This study was carried out to check the efficacy of empagliflozin in heart failure patients. For...
VISUALIZED: Trial Study to Show Empagliflozin Outcomes In...
Read further: Trial Study to Show Empagliflozin Outcomes In Patients of Chronic Heart Failure and...
Trial to Study Comprehensive Lifestyle Intervention for...
Eligible asymptomatic individuals between the age range 40-50 years from the progression of early...
Hemodynamic Trial Study to Show Riociguat Outcomes In Patients...
The DYNAMIC trial study was a randomized, multicenter, placebo-controlled, double-blind IIB trial...
Study to Explore Cangrelor vs. Glycoprotein IIa/IIb Inhibitors...
During dual antiplatelet therapy, Cangrelor or eptifibatide, etc., short-acting parental...
ARNI vs. ACEi In Reducing Heart Failure Events Post-Myocardial...
Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are drugs...
AHA Construct of Cardiovascular Health: Life’s Essential 8
The American Heart Association (AHA) worked on cardiovascular health, and in 2010 they defined a...